![Salvatore Alesci](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Salvatore Alesci
Corporate Officer/Principal bei TAKEDA PHARMACEUTICAL COMPANY LIMITED
Aktive Positionen von Salvatore Alesci
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - | - |
Invea Therapeutics, Inc.
![]() Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2022 | - |
Karriereverlauf von Salvatore Alesci
Statistik
International
Japan | 2 |
Vereinigte Staaten | 2 |
Operativ
Corporate Officer/Principal | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
Private Unternehmen | 1 |
---|---|
Invea Therapeutics, Inc.
![]() Invea Therapeutics, Inc. BiotechnologyHealth Technology Invea Therapeutics, Inc. operates as a biotechnology company developing small molecule oral therapeutics for immune-mediated inflammatory diseases. Its products include INVA8001 and INVA8003. The company was founded on October 20, 2021. The company is headquartered in Guilford, CT. | Health Technology |
- Börse
- Insiders
- Salvatore Alesci
- Erfahrung